XOMA Royalty (XOMA) Shares Outstanding (2010 - 2026)
XOMA Royalty (XOMA) reported Shares Outstanding (Entity) of $11.9 million for Q1 2026, little changed on a YoY basis from $12.0 million in Q1 2025, and little changed sequentially from $11.9 million in Q4 2025.
XOMA Royalty (XOMA) Shares Outstanding (2010 - 2026) Analysis & Trends
XOMA Royalty (XOMA) has 17 years of Shares Outstanding (Entity) data on file, last reported at $11.9 million in Q1 2026.
- For the quarter ending Q1 2026, Shares Outstanding (Entity) changed 0.36% year-over-year to $11.9 million; the trailing twelve-month figure through Mar 2026 stood at $11.9 million (changed 0.36% YoY), and the FY2025 full-year result was $11.9 million, down 0.78% from the prior year.
- Shares Outstanding (Entity) steadied at $11.9 million in Q1 2026, from $11.9 million in the prior quarter.
- In the past five years, Shares Outstanding (Entity) ranged from a high of $12.1 million in Q2 2025 to a low of $11460.0 in Q1 2023.
- A 5-year average of $8.5 million and a median of $11.5 million in 2022 frame the typical range for Shares Outstanding (Entity).
- Across the five-year window, Shares Outstanding (Entity) slumped 99.9% in 2023 and soared 103120.11% in 2025, its largest moves.
- Tracing XOMA's Shares Outstanding (Entity) over 5 years: stood at $11.5 million in 2022, then sank by 40.52% to $6.8 million in 2023, then jumped by 75.43% to $12.0 million in 2024, then decreased by 0.78% to $11.9 million in 2025, then climbed by 0.43% to $11.9 million in 2026.
- Business Quant data shows XOMA's Shares Outstanding (Entity) at $11.9 million in Q1 2026, $11.9 million in Q4 2025, and $12.1 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 6,012.74 Bn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | 47.82 Bn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 118.76 Bn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1.44 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 254.10 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 400.00 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 62.06 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 198.10 Mn |
| 10 | XOMA Royalty | 478.42 Mn | 412.34 Mn | - | 11.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.89 Mn |
| Dec 31, 2025 | 12.08 Mn |
| Sep 17, 2025 | 12.01 Mn |
| Jun 30, 2025 | 12.01 Mn |
| Mar 31, 2025 | 11.97 Mn |
| Dec 31, 2024 | 11.70 Mn |
| Sep 30, 2024 | 11.71 Mn |
| Jun 30, 2024 | 11.64 Mn |
| Mar 31, 2024 | 11,580.00 |
| Dec 31, 2023 | 6.81 Mn |
| Sep 30, 2023 | 11,473.00 |
| Jun 30, 2023 | 11,466.00 |
| Mar 31, 2023 | 11,460.00 |
| Dec 31, 2022 | 11.41 Mn |
| Sep 30, 2022 | 11.45 Mn |
| Jun 30, 2022 | 11.42 Mn |
| Mar 31, 2022 | 11.33 Mn |
| Dec 31, 2021 | 11.29 Mn |
| Sep 30, 2021 | 11.31 Mn |
| Jun 30, 2021 | 11.29 Mn |